Your Best Stock

AstraZeneca AZN

$165.63
+$2.30 (+1.41%)
Market open · Sep 24, 2:00 pm ET
After hours $164.57 +0.76%
Open$162.93
Prev close$163.33
Day range$162.92 – $166.25
Volume2.12M
Market cap$256.87B
P/E (TTM)24.8
Dividend yield1.91%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$15.38B+6.4% YoY
Operating profit$3.16B-9.8% YoY
Net profit$2.51B+2.5% YoY
Diluted EPS$1.61+2.5% YoY
Free cash flow-$240.00M-116.4% YoY
Operating cash flow$2.87B

Revenue, last 8 quarters

$13.6BSep '24$14.9BDec '24$13.6BMar '25$14.5BJun '25$15.2BSep '25$15.5BDec '25$15.3BMar '26$15.4BJun '26

Net profit, last 8 quarters

$1.4BSep '24$1.5BDec '24$2.9BMar '25$2.4BJun '25$2.5BSep '25$2.3BDec '25$3.1BMar '26$2.5BJun '26

Diluted EPS by quarter

0.91Sep '240.96Dec '241.87Mar '251.57Jun '251.62Sep '251.49Dec '251.97Mar '261.61Jun '26

Free cash flow by quarter

$2.0BSep '24$2.0BDec '24$2.7BMar '25$1.5BJun '25$3.4BSep '25$1.1BDec '25$1.8BMar '26$-240.0MJun '26

Annual revenue

$26.6BFY20$37.4BFY21$44.4BFY22$45.8BFY23$54.1BFY24$58.7BFY25

Profitability & balance sheet

Gross margin81.9%
Operating margin22.1%
Net margin17.0%
Return on equity22.0%
Return on assets9.2%
Return on invested capital14.4%
Current ratio0.89
Liabilities / assets56.5%
Cash & investments$4.97B
Total debt$31.81B
Net cash (debt)-$26.85B
Free cash flow / sales9.8%

Where the revenue comes from

Quarter 2025/FY

By region

  • US$23.97B 40.8%
  • China$6.64B 11.3%
  • Other$5.03B 8.6%
  • UK$4.36B 7.4%
  • Rest of Europe$4.32B 7.4%
  • Japan$3.56B 6.1%
  • Germany$2.89B 4.9%
  • Asia, Africa and Australasia$2.72B 4.6%
  • The Americas$2.63B 4.5%
  • Sweden$2.62B 4.5%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $15.38B $15.29B $58.74B $15.50B $15.19B
Total Operating Revenue $15.38B $15.29B $58.74B $15.50B $15.19B
Cost of Revenue $2.52B $2.68B $10.63B $3.12B $2.80B
Gross Profit $12.86B $12.61B $48.11B $12.39B $12.39B
Operating Expense $9.70B $8.36B $34.78B $9.41B $8.81B
Selling and Admin Expenses $5.80B $5.06B $20.77B $5.65B $5.23B
-Selling & Marketing Expense $145.00M $141.00M $579.00M $153.00M $148.00M
-General & Admin Expense $5.65B $4.92B $20.20B $5.49B $5.09B
Research & Development $4.05B $3.49B $14.23B $3.86B $3.66B
Other Operating Expenses -$152.00M – $134.00M – -$89.00M
Operating Profit $3.16B $4.25B $13.33B $2.98B $3.58B
Net Non-Operating Interest Income (Expense) -$355.00M -$320.00M -$1.25B -$349.00M -$349.00M
Non-Operating Interest Income $80.00M $73.00M $360.00M $135.00M $85.00M
Non-Operating Interest Expense $435.00M $393.00M $1.61B $484.00M $434.00M
Pretax Profit $2.80B $3.91B $12.40B $2.63B $3.24B
Tax $291.00M $833.00M $2.17B $300.00M $709.00M
Net Profit $2.51B $3.08B $10.23B $2.33B $2.54B
Profit from Continuing Operations $2.51B $3.08B $10.23B $2.33B $2.54B
Minority Interests $1.00M $1.00M $8.00M $3.00M $2.00M
Net Income to Parent Company $2.51B $3.08B $10.23B $2.33B $2.53B
Other Preferred Stock Dividends $0.00 $0.00 $0.00 $0.00 $0.00
Net Income to Common Stockholders $2.51B $3.08B $10.23B $2.33B $2.53B
Basic EPS $1.61 $1.99 $6.60 $1.50 $1.64
Diluted EPS $1.61 $1.97 $6.54 $1.49 $1.62
Dividend Per Share $0.00 $2.15 $3.13 $0.00 $1.02
Special Income (Charges) – – $416.00M – –
-Less:Restructuring and Mergern & Acquisition – – -$44.00M – –
-Less:Other Special Charges – – -$372.00M – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $115.83B $114.02B $114.07B $114.07B $114.46B
Total Current Assets $27.97B $29.61B $28.72B $28.72B $29.94B
Cash and Cash Equivalents & Short-Term Investments $4.97B $7.68B $5.72B $5.72B $8.18B
-Cash and Cash Equivalents $4.89B $7.56B $5.71B $5.71B $8.14B
-Short Term Investments $75.00M $115.00M $8.00M $8.00M $39.00M
-Accounts Receivable $14.33B $14.11B $10.24B $10.24B $14.34B
-Taxes Receivable $1.66B $1.06B $1.16B $1.16B $815.00M
Inventory $6.93B $6.57B $6.56B $6.56B $6.59B
Total Non-Current Assets $87.87B $84.40B $85.35B $85.35B $84.52B
Net PPE $16.30B $14.94B $14.70B $14.70B $13.78B
-Gross PPE $16.30B $14.94B $25.25B $25.25B $13.78B
-Long Term Equity Investment $297.00M $306.00M $302.00M $302.00M $296.00M
Financial Assets $394.00M $382.00M $498.00M $498.00M $502.00M
Goodwill and Other Intangible Assets $58.90B $58.10B $59.09B $59.09B $59.41B
-Goodwill $21.18B $21.19B $21.24B $21.24B $21.22B
-Other Intangible Assets $37.72B $36.91B $37.85B $37.85B $38.19B
Total Liabilities $65.46B $66.63B $65.36B $65.36B $68.49B
Total Current Liabilities $31.55B $32.57B $30.62B $30.62B $34.05B
Payables $24.36B $23.80B $7.50B $7.50B $26.30B
-Accounts Payable $22.89B $22.51B $3.82B $3.82B $25.03B
-Total Tax Payable $1.47B $1.30B $1.66B $1.66B $1.27B
Short-Term Debt and Capital Lease Obligation $6.23B $7.96B $3.01B $3.01B $6.55B
-Current Debt $5.81B $7.58B $2.63B $2.63B $6.17B
-Current Capital Lease Obligation $426.00M $383.00M $382.00M $382.00M $379.00M
Current Provisions $850.00M $704.00M $686.00M $686.00M $1.18B
Total Non-Current Liabilities $33.91B $34.06B $34.74B $34.74B $34.43B
Long Term Accounts Payable and Other Payables $2.62B $2.77B $2.94B $2.94B $2.55B
Long Term Debt and Capital Lease Obligation $26.01B $25.96B $26.14B $26.14B $26.08B
-Long Term Debt $23.68B $24.45B $24.72B $24.72B $24.70B
-Long Term Capital Lease Obligation $2.32B $1.51B $1.42B $1.42B $1.38B
Derivative Product Liabilities $3.00M $8.00M $0.00 $0.00 $0.00
Non-Current Liabilities $967.00M $904.00M $918.00M $918.00M $929.00M
Total Equity $50.37B $47.38B $48.72B $48.72B $45.97B
Stockholders' Equity $50.30B $47.33B $48.67B $48.67B $45.89B
Capital Stock $388.00M $388.00M $388.00M $388.00M $388.00M
-Common Stock $388.00M $388.00M $388.00M $388.00M $388.00M
Additional Paid-In Capital $35.28B $35.28B $35.42B $35.42B $35.24B
Retained Earnings $12.59B $9.67B $10.97B $10.97B $8.21B
Minority Interests $75.00M $51.00M $52.00M $52.00M $83.00M
Other Current Assets – $175.00M – – –
-Other Receivables – – $2.91B $2.91B –
Prepaid Assets – – $2.03B $2.03B –
Restricted Cash – – $22.00M $22.00M –
-Accumulated Depreciation – – -$10.54B -$10.54B –
-Available for Sale Securities – – $2.21B $2.21B –
Non-Current Prepaid Assets – – $559.00M $559.00M –
Defined Pension Benefit – – $106.00M $106.00M –
-Other Payable – – $2.02B $2.02B –
Non-Current Accrued Expenses – – $85.00M $85.00M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $2.87B $3.36B $14.58B $2.34B $5.13B
Net Income from Continuing Operations $2.80B $3.91B $12.40B $2.63B $3.24B
Other Non-Cash Items $373.00M $68.00M $1.82B $272.00M $637.00M
Change in Working Capital -$438.00M -$1.00B -$1.14B -$1.20B $835.00M
Net cash flow from investing -$2.91B -$1.79B -$6.81B -$1.45B -$2.00B
Net PPE Purchase and Sale -$759.00M -$539.00M -$2.80B -$1.03B -$686.00M
Net Intangibles Purchase and Sale -$2.22B -$946.00M -$2.96B -$211.00M -$1.04B
Net Business Purchase and Sale -$33.00M -$281.00M -$1.24B -$273.00M -$338.00M
Net Investment Purchase and Sale $43.00M -$93.00M -$98.00M -$2.00M -$23.00M
Financing Cash Flow -$2.59B $267.00M -$7.54B -$3.28B -$2.07B
Net Issuance Payments Of Debt -$2.37B $4.23B -$1.65B -$3.02B -$356.00M
Net Common Stock Issuance -$40.00M -$602.00M -$481.00M $10.00M -$14.00M
Cash Dividends Paid -$1.00M -$3.29B -$4.97B -$3.00M -$1.61B
Net Other Financing Charges $0.00 -$72.00M -$70.00M -$169.00M -$3.00M
Ending Cash Balance $4.88B $7.51B $5.70B $5.70B $8.08B
Net Change in Cash -$2.64B $1.83B $223.00M -$2.39B $1.06B
Beginning Cash Balance $7.51B $5.70B $5.43B $8.08B $7.03B
Effect of Exchange Rate Changes $9.00M -$18.00M $46.00M $4.00M -$12.00M
Free Cash Flow -$240.00M $1.82B $8.67B $1.06B $3.41B
-Change in Receivables – – -$1.73B – –
-Change in Inventory – – -$755.00M – –
Scroll to Top